コンテンツへスキップ
Merck
  • Uptake and effects of a mixture of widely used therapeutic drugs in Eruca sativa L. and Zea mays L. plants.

Uptake and effects of a mixture of widely used therapeutic drugs in Eruca sativa L. and Zea mays L. plants.

Ecotoxicology and environmental safety (2014-07-22)
Milena Marsoni, Fabrizio De Mattia, Massimo Labra, Antonia Bruno, Antonella Bruno, Marcella Bracale, Candida Vannini
要旨

Pharmaceutically active compounds (PACs) are continuously dispersed into the environment due to human and veterinary use, giving rise to their potential accumulation in edible plants. In this study, Eruca sativa L. and Zea mays L. were selected to determine the potential uptake and accumulation of eight different PACs (Salbutamol, Atenolol, Lincomycin, Cyclophosphamide, Carbamazepine, Bezafibrate, Ofloxacin and Ranitidine) designed for human use. To mimic environmental conditions, the plants were grown in pots and irrigated with water spiked with a mixture of PACs at concentrations found in Italian wastewaters and rivers. Moreover, 10× and 100× concentrations of these pharmaceuticals were also tested. The presence of the pharmaceuticals was tested in the edible parts of the plants, namely leaves for E. sativa and grains for Z. mays. Quantification was performed by liquid chromatography mass spectroscopy (LC/MS/MS). In the grains of 100× treated Z. mays, only atenolol, lincomycin and carbamazepine were above the limit of detection (LOD). At the same concentration in E. sativa plants the uptake of all PACs was >LOD. Lincomycin and oflaxacin were above the limit of quantitation in all conditions tested in E. sativa. The results suggest that uptake of some pharmaceuticals from the soil may indeed be a potential transport route to plants and that these environmental pollutants can reach different edible parts of the selected crops. Measurements of the concentrations of these pharmaceuticals in plant materials were used to model potential adult human exposure to these compounds. The results indicate that under the current experimental conditions, crops exposed to the selected pharmaceutical mixture would not have any negative effects on human health. Moreover, no significant differences in the growth of E. sativa or Z. mays plants irrigated with PAC-spiked vs. non-spiked water were observed.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
カルバマゼピン, powder
Sigma-Aldrich
アテノロール, ≥98% (TLC), powder
Sigma-Aldrich
オフロキサシン, fluoroquinolone antibiotic
Sigma-Aldrich
リンコマイシン 塩酸塩, 96.0-102.0% (HPLC)
Sigma-Aldrich
ラニチジン 塩酸塩, solid
Sigma-Aldrich
ベザフィブラート, ≥98%, solid
Supelco
Carbamazepine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
リンコマイシン 塩酸塩, ≥90% (TLC)
Supelco
アルブテロール硫酸塩, Pharmaceutical Secondary Standard; Certified Reference Material
USP
オフロキサシン, United States Pharmacopeia (USP) Reference Standard
Supelco
オフロキサシン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
リンコマイシン 塩酸塩, BioReagent, suitable for cell culture
USP
カルバマゼピン, United States Pharmacopeia (USP) Reference Standard
Supelco
Atenolol solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
カルバマゼピン, Pharmaceutical Secondary Standard; Certified Reference Material
USP
アテノロール, United States Pharmacopeia (USP) Reference Standard
Supelco
カルバマゼピン, analytical standard
Sigma-Aldrich
サルブタモール ヘミ硫酸塩, ≥98%
USP
ラニチジン 塩酸塩, United States Pharmacopeia (USP) Reference Standard
USP
リンコマイシン 塩酸塩 一水和物, United States Pharmacopeia (USP) Reference Standard
サルブタモール ヘミ硫酸塩, European Pharmacopoeia (EP) Reference Standard
Supelco
ラニチジン 塩酸塩, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
リンコマイシン 塩酸塩 一水和物, VETRANAL®, analytical standard
Sigma-Aldrich
カルバマゼピン, meets USP testing specifications
カルバマゼピン, European Pharmacopoeia (EP) Reference Standard
リンコマイシン 塩酸塩 一水和物, European Pharmacopoeia (EP) Reference Standard
Supelco
オフロキサシン, VETRANAL®, analytical standard